Common heart surgery drug may be more dangerous than cheaper alternatives: study
Tuesday, December 2, 2008 - 15:25
in Health & Medicine
The risk of death during cardiac surgery tended to be higher among patients who were given the drug aprotinin to control blood loss compared with less expensive alternatives, a Canadian review suggests.